Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Asset Writedowns and Impairment: 2014-2025

Historic Asset Writedowns and Impairment for Fortress Biotech (FBIO) over the last 5 years, with Sep 2025 value amounting to $76,000.

  • Fortress Biotech's Asset Writedowns and Impairment was N/A to $76,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $873,000, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is 17.47% up from last year.
  • Fortress Biotech's Asset Writedowns and Impairment amounted to $76,000 in Q3 2025, which was up 117.23% from -$441,000 recorded in Q2 2025.
  • Fortress Biotech's Asset Writedowns and Impairment's 5-year high stood at $3.1 million during Q2 2023, with a 5-year trough of -$441,000 in Q2 2025.
  • In the last 3 years, Fortress Biotech's Asset Writedowns and Impairment had a median value of $160,500 in 2023 and averaged $849,625.
  • As far as peak fluctuations go, Fortress Biotech's Asset Writedowns and Impairment tumbled by 267.11% in 2021, and later soared by 10,038.71% in 2023.
  • Over the past 5 years, Fortress Biotech's Asset Writedowns and Impairment (Quarterly) stood at $115,000 in 2021, then spiked by 138.26% to $274,000 in 2022, then skyrocketed by 10,038.71% to $3.1 million in 2023, then dropped by 15.72% to $1.0 million in 2024, then crashed by 116.65% to $76,000 in 2025.
  • Its last three reported values are $76,000 in Q3 2025, -$441,000 for Q2 2025, and $195,000 during Q1 2025.